Fortune Business Insights values the global AI in healthcare market at $39.34 billion in 2025, projecting it to reach $1.03 trillion by 2034. That's roughly 44% compound annual growth — the fastest of any vertical. The combination of massive addressable cost (US healthcare alone is $4.5T/year) and clear use cases drives the trajectory.
The ROI data is unusually concrete for an emerging technology. Microsoft and IDC research shows healthcare organisations earn $3.20 for every $1 invested in AI, with the return realised within 14 months on average. Google Cloud's research confirms 73% of healthcare leaders report positive ROI within the first year.
The gap between adopters and non-adopters is already visible in operational metrics. Hospitals using AI for an administrative workflow see billing cycles shortened by 40%. Those using clinical AI for radiology screening achieve 93% accuracy — matching or exceeding specialist performance. And 79% of healthcare organisations now use AI in some capacity.
The transformation is happening across the care continuum: diagnostics, drug discovery, patient engagement, and back-office operations. The organisations that deployed AI early are seeing compound benefits — better outcomes attract better talent, which improves care quality, which attracts more patients.